Canada 2020: Dr. Penny Corkum / Dalhousie University, IWK Health Centre, Colchester East Hants Health Authority

Delegate: Dr. Penny Corkum

Affiliations: Dalhousie University, IWK Health Centre, Colchester East Hants Health Authority

Short Bio: Dr. Penny Corkum is a Registered Psychologist and Professor in the Clinical Psychology Program with the Department of Psychology and Neuroscience at Dalhousie University. Her clinical practice, research, and teaching are in the area of child psychopathology and sleep. Dr. Corkum has a particular interest in Attention Deficit/Hyperactivity Disorder (ADHD) and sleep problems in elementary school-aged children. Dr. Corkum is the Director of the ADHD Clinic at the Colchester Regional Hospital, and Scientific Staff at the IWK Health Centre.

Activity: Dr. Penny Corkum will be hosting a Facebook Live presentation on “The Impact of Sleep in Children with Neurodevelopemtal Disorders and the Better Nights, Better Days Program” on Friday, March 13 at 1:00 pm Atlantic Time.

Up to 90% of Canadian children with neurodevelopmental disorders (NDD) experience insomnia symptoms including trouble falling asleep, staying asleep, and/or waking too early. Poor sleep can have a significant impact on the quality of life of children with NDD and can result in increased:

• challenges learning and paying attention
• difficulties controlling emotions
• academic struggles
• challenges with peers
• symptom presentation

Parents of children with NDD and sleep problems also have experience more stress and increased parenting challenges. The good news is that for the majority of children with NDD, these sleep problems can be treated through psychological interventions! Developed by Dr. Penny Corkum (Dalhousie University; IWK Health Centre), Dr. Shelly Weiss (University of Toronto; SickKids), and their colleagues at institutions across Canada, Better Nights, Better Days for Children with Neurodevelopmental Disorders (BNBD-NDD) ( is an online evidence-based, transdiagnostic sleep program for parents with children ages 4-12 years old with Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Cerebral Palsy (CP) and Fetal Alcohol Spectrum Disorder (FASD) that experience insomnia. The BNBD-NDD research team is looking for families of children with ADHD, ASD, CP, and/or FASD from across Canada to participate in this research study to evaluate the effectiveness of BNBD-NDD.

Location: Facebook

Date of Activity: Friday, March 13, 2020

Submitted By: Laura Keeler, Research Associate